Natural health product · NPN 80044392
Transdermal Nicotine Patch
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed August 26, 2013; licence last revised March 16, 2023.
- Natural Product Number (NPN)
- 80044392
- Licence holder
- Teva Canada LimitedToronto, Ontario, Canada
- Dosage form
- Patch
- Route
- Transdermal
- Licensing route
- TPD Cat IV/LS
- First licensed
- August 26, 2013
- Licence last revised
- March 16, 2023
Also sold as
Other product names on the same licence.
- Nicotine Patch
- Stop Smoking System 14 mg
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| 3-(1-Methyl-2-pyrrolidinyl)pyridine | 45.75 mg | Nicotine |
| 3-(1-Methyl-2-pyrrolidinyl)pyridine | 14 mg | Nicotine |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Transdermal nicotine patch is indicated as a temporary aid to help you stop smoking by reducing withdrawal symptoms such as nicotine cravings when used as part of a smoking cessation program.
Non-medicinal ingredients
Polyisobutylene; Polyethylene terephthalate; Polyethylene; Polyester-1; BHT; Ethylene Vinyl Acetate